Affiliation: Johns Hopkins University
- Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reductionDuvuru Geetha
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224 2780, USA
Medicine (Baltimore) 90:296-302. 2011..Post-PVAN rejection leads to graft failure. Early repeat allograft biopsy should be considered in the management of PVAN with persistent graft dysfunction...
- Results of repeat renal transplantation after graft loss from BK virus nephropathyDuvuru Geetha
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Transplantation 92:781-6. 2011..The aims of this study are to (1) describe the management of patients undergoing retransplantation after allograft loss in the setting of BKVN and (2) to identify risk factors for BK virus replication in the retransplant...
- Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsyDuvuru Geetha
Division of Nephrology, Johns Hopkins Bayview Medical Center, 301 Mason Lord Drive, Room 2509, Baltimore, MD 21224, USA
J Rheumatol 39:1413-7. 2012..In patients who are in apparent clinical remission, presence of persistent or new-onset microscopic hematuria may reflect active vasculitis, damage, or other glomerular pathology...
- Ureteral stents: a novel risk factor for polyomavirus nephropathyAbraham Thomas
Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21224, USA
Transplantation 84:433-6. 2007..Our findings reveal that the presence of a ureteral stent is associated with an increase in the risk of PVN...
- Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experienceDuvuru Geetha
Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
Transplantation 91:1370-5. 2011..We report our experience with AAV patients who underwent KTX at our institutions between 1996 and 2010. Median follow-up was 64 months...
- Advances in therapy for ANCA-associated vasculitisDuvuru Geetha
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Curr Rheumatol Rep 14:509-15. 2012..For patients with life-threatening disease, plasma exchange may be an effective adjuvant therapy. This article reviews seminal studies from the past decade that have contributed to the current standard of care...
- Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritisPurva Sharma
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Am J Kidney Dis 60:157-9. 2012..As exemplified by this case, it is important to consider fibrillary GN in the differential diagnosis of crescentic GN with linear immunoglobulin G deposits within the GBM. Electron microscopy is crucial to make this diagnosis...
- Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipientsAdnan Sharif
Renal Institute of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom
Clin J Am Soc Nephrol 7:1320-7. 2012..BKVAN link to rejection and graft accommodation phenotype were also explored. The Johns Hopkins Institutional Review Board approved this study...
- Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitisDuvuru Geetha
Division of Nephrology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Rheumatol 37:1705-8. 2010..Antineutrophil cytoplasmic antibody-associated vasculitis is an important cause of endstage renal disease. Our aim was to investigate how the underlying vasculitis diagnosis may influence outcomes following renal transplant...
- Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agentDuvuru Geetha
Department of Medicine, The Johns Hopkins Hospital Medical Institutions, Baltimore, Maryland 21231, USA
Transplantation 73:1933-6. 2002..High level expression of BKV large T antigen in the primary and metastatic carcinoma, but not in the nonneoplastic urothelium, implicates BKV as an etiologic agent in the development of this tumor...